![Steven Glauser](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 300 701 $ in data 31/07/2026
Mr. Steven J.
Glauser is an Independent Non-Executive Director at ZEO ScientifiX, Inc. He is on the Board of Directors at ZEO ScientifiX, Inc. and National Jewish Health, Inc. Mr. Glauser was previously employed as a Principal by Sorrento Therapeutics, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/01/2026 | 258.334 ( 3,3% ) | 300 701 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ORGANICELL REGENERATIVE MEDICINE INC | Direttore/Membro del Consiglio | 23/09/2022 |
National Jewish Health, Inc.
 National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
ZEO ScientifiX, Inc.
 ZEO ScientifiX, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops biological therapeutics for the treatment of degenerative diseases | Health Technology |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
National Jewish Health, Inc.
National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
